ERBB2 and breast cancer: Alongside histological laboratory work to establish characteristics such as the tumour's size and whether it has spread to the lymph nodes (LN), the examination of the ER, PR and HER2 status of tumour tissue to determine molecular subtype is a routine aspect of breast cancer diagnosis in the UK.